After completing the 12-month PGY-2 Pharmacy Residency in Oncology at Mayo Clinic Hospital in Phoenix/Scottsdale, Arizona, you will be a proficient, independent practitioner capable of providing advanced pharmacotherapeutic care to oncology and hematology patients.

The purpose of the PGY-2 Pharmacy Residency in Oncology is to build on Doctor of Pharmacy (PharmD) education and PGY-1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY-2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY-2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

Program highlights

The residency provides the high-quality didactic and clinical experiences needed to create a well-rounded, independent clinical pharmacist. As a PGY-2 pharmacy resident, you will:

• Participate as a member of the interdisciplinary team in an environment shaped by the core values of teamwork, collaboration, and mutual respect
• Develop pharmacotherapy expertise in cancer-directed therapies
• Experience professional growth in a teaching environment that is patient-centered and science-driven
• Contribute to interdisciplinary health care teams by offering patient-specific therapeutic interventions designed to treat, cure, rehabilitate, and alleviate medial conditions and diseases unique to cancer patients
• Enhance your research skills by completing research curriculum and leading an oncology focused clinical research project
• Expand your communication skills through leading interdisciplinary discussions, delivering informal and formal presentations, and writing a research manuscript
• Create connections with fellow pharmacists through professional organizations and conferences
• Experience professional growth in a setting that is supportive of learner well-being
• Learn in a structured yet flexible curriculum to fit your future career goals

Program history

The PGY-2 Oncology Pharmacy Residency at Mayo Clinic Hospital in Phoenix/Scottsdale, Arizona, is in candidate status with ASHP. The first resident started the program in July 2022. One candidate will be selected on a competitive basis each year.

Facilities

The campus in Phoenix/Scottsdale, Arizona, includes extensive outpatient facilities and Mayo Clinic Hospital, a seven-story facility with 316 beds, 21 operating suites, and an emergency department.

Mayo Clinic Cancer Center is a National Cancer Institute-designated comprehensive cancer center with an international presence. More than 150,000 people receive cancer treatment at Mayo Clinic each year, making it one of the largest cancer treatment facilities in the nation. Hundreds of clinical trials led by Mayo Clinic physicians and scientists are available for patients, including trials through the Alliance for Clinical Trials in Oncology, Phase I Program, Phase II Consortium, and Cancer Prevention Network. Additional trials are available through cooperative research affiliations and collaborations with the National Cancer Institute and other clinical trial groups.

The Arizona campus is currently undergoing the largest capital expansion project in Mayo Clinic history. By 2024, Mayo Clinic will double the size of the Phoenix campus, with new construction and additions to existing facilities to support activities across the Practice, Research, and Education shields.